![Carol Waldo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Carol Waldo worked as the Vice President of Regulatory Affairs at Cubist Pharmaceuticals LLC.
She then served as the Head of Regulatory Affairs at Spero Therapeutics, Inc. from 2016 to 2019.
Ms. Waldo's most recent position was as the Senior VP of Regulatory Affairs & Quality Assurance at Cidara Therapeutics, Inc. from 2021 to 2023.
She completed her undergraduate degree at North Central College.
Antiguos cargos conocidos de Carol Waldo.
| Empresas | Cargo | Fin |
|---|---|---|
| CIDARA THERAPEUTICS | Corporate Officer/Principal | 01/08/2023 |
| SPERO THERAPEUTICS, INC. | Consejero General | 01/02/2019 |
| CUBIST PHARMACEUTICALS INC | Consejero General | - |
Formación de Carol Waldo.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
18
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug-resistant bacterial infections | Health Technology |
North Central College
 North Central College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
- Bolsa de valores
- Insiders
- Carol Waldo
